SCHEMBL10089977

SCHEMBL10089977

Cc1cc(Cl)cc(C(=O)NCc2cccc(OC(F)F)c2)c1NC(=O)c1cc(Cn2nnc(C(F)F)n2)nn1-c1ncccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.36
KCNH2 Q12809 1/20 0.36
KCNB1 Q14721 1/20 0.36
KLKB1 P03952 1/20 0.35
MMP13 P45452 3/20 0.35
TP53 P04637 2/20 0.35
HDAC6 Q9UBN7 2/20 0.33
ROCK2 O75116 2/20 0.33
ROCK1 Q13464 2/20 0.33
PPARG P37231 2/20 0.33
KIT P10721 1/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33
TUBB2A Q13885 1/20 0.33
TUBB8 Q3ZCM7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10089922 0.95 ABCB1 (0.39) KCNB1ROCK2ROCK1PPARGABCB1
SCHEMBL10089909 0.94 PPARG (0.36) MMP13PPARGNR1I2GPR6
SCHEMBL10089881 0.93 GPR6 (0.36) KCNA5KCNH2KCNB1KLKB1MMP13
SCHEMBL10089916 0.92 KCNB1 (0.36) KCNA5KCNH2KCNB1KLKB1MMP13
SCHEMBL10089844 0.89 MAPK8 (0.35) TP53KMT2AGPR6
SCHEMBL10090044 0.89 PDE2A (0.35) KCNH2KLKB1PPARGHPGD
SCHEMBL13085289 0.88 ALDH1A1 (0.33)
SCHEMBL10090032 0.88 GPR6 (0.36) KCNB1ROCK2ROCK1GPR6ABCB1
SCHEMBL13085131 0.88 DHODH (0.33)
SCHEMBL10089932 0.87 GPR6 (0.36) MMP13PPARGNR1I2GPR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791143-B2 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2014-07-29 US disclosed
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains DDT, ADCY1, ANTXR2 KCNA5 846/4885KCNH2 617/4885KCNB1 1400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.